Cited In for PMID: 23782942

Year	Number of Results
2013	2
2014	2
2015	1
2016	1
2017	1
2020	2
2021	1
2023	2
2024	1

1

Growth hormone potentiates 17β-estradiol-dependent breast cancer cell proliferation independently of IGF-I receptor signaling.

Felice DL, El-Shennawy L, Zhao S, Lantvit DL, Shen Q, Unterman TG, Swanson SM, Frasor J. Felice DL, et al. Endocrinology. 2013 Sep;154(9):3219-27. doi: 10.1210/en.2012-2208. Epub 2013 Jun 19. Endocrinology. 2013. PMID: 23782942 Free PMC article.

2

Machine learning-assisted high-content imaging analysis of 3D MCF7 microtissues for estrogenic effect prediction.

Li H, Seada H, Madnick S, Zhao H, Chen Z, Li F, Zhu F, Hall S, Boekelheide K. Li H, et al. Sci Rep. 2024 Feb 6;14(1):2999. doi: 10.1038/s41598-024-53323-6. Sci Rep. 2024. PMID: 38316851 Free PMC article.

3

IGF-1R targeting in cancer - does sub-cellular localization matter?

Soni UK, Jenny L, Hegde RS. Soni UK, et al. J Exp Clin Cancer Res. 2023 Oct 20;42(1):273. doi: 10.1186/s13046-023-02850-7. J Exp Clin Cancer Res. 2023. PMID: 37858153 Free PMC article. Review.

4

Role of Estrogen and Estrogen Receptor in GH-Secreting Adenomas.

Voltan G, Mazzeo P, Regazzo D, Scaroni C, Ceccato F. Voltan G, et al. Int J Mol Sci. 2023 Jun 8;24(12):9920. doi: 10.3390/ijms24129920. Int J Mol Sci. 2023. PMID: 37373068 Free PMC article. Review.

5

Mammary Tumors Growing in the Absence of Growth Hormone Are More Sensitive to Doxorubicin Than Wild-Type Tumors.

Lantvit DD, Unterberger CJ, Lazar M, Arneson PD, Longhurst CA, Swanson SM, Marker PC. Lantvit DD, et al. Endocrinology. 2021 Apr 1;162(4):bqab013. doi: 10.1210/endocr/bqab013. Endocrinology. 2021. PMID: 33475144 Free PMC article.

6

Growth Hormone Upregulates Mediators of Melanoma Drug Efflux and Epithelial-to-Mesenchymal Transition In Vitro and In Vivo.

Qian Y, Basu R, Mathes SC, Arnett NA, Duran-Ortiz S, Funk KR, Brittain AL, Kulkarni P, Terry JC, Davis E, Singerman JT, Henry BE, List EO, Berryman DE, Kopchick JJ. Qian Y, et al. Cancers (Basel). 2020 Dec 4;12(12):3640. doi: 10.3390/cancers12123640. Cancers (Basel). 2020. PMID: 33291663 Free PMC article.

7

Unraveling the Resistance of IGF-Pathway Inhibition in Ewing Sarcoma.

de Groot S, Röttgering B, Gelderblom H, Pijl H, Szuhai K, Kroep JR. de Groot S, et al. Cancers (Basel). 2020 Nov 29;12(12):3568. doi: 10.3390/cancers12123568. Cancers (Basel). 2020. PMID: 33260481 Free PMC article. Review.

8

MiR-139 suppresses β-casein synthesis and proliferation in bovine mammary epithelial cells by targeting the GHR and IGF1R signaling pathways.

Cui Y, Sun X, Jin L, Yu G, Li Q, Gao X, Ao J, Wang C. Cui Y, et al. BMC Vet Res. 2017 Nov 25;13(1):350. doi: 10.1186/s12917-017-1267-1. BMC Vet Res. 2017. PMID: 29178948 Free PMC article.

9

Growth hormone is permissive for neoplastic colon growth.

Chesnokova V, Zonis S, Zhou C, Recouvreux MV, Ben-Shlomo A, Araki T, Barrett R, Workman M, Wawrowsky K, Ljubimov VA, Uhart M, Melmed S. Chesnokova V, et al. Proc Natl Acad Sci U S A. 2016 Jun 7;113(23):E3250-9. doi: 10.1073/pnas.1600561113. Epub 2016 May 25. Proc Natl Acad Sci U S A. 2016. PMID: 27226307 Free PMC article.

10

Minireview: Were the IGF Signaling Inhibitors All Bad?

Beckwith H, Yee D. Beckwith H, et al. Mol Endocrinol. 2015 Nov;29(11):1549-57. doi: 10.1210/me.2015-1157. Epub 2015 Sep 14. Mol Endocrinol. 2015. PMID: 26366975 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

12 results

Results by year